Literature DB >> 16243066

Pluronic Block Copolymers for Gene Delivery.

Alexander Kabanov1, Jian Zhu, Valery Alakhov.   

Abstract

Amphiphilic block copolymers of poly(ethylene oxide) and poly(propylene oxide) called Pluronic or poloxamer are commercially available pharmaceutical excipients. They recently attracted considerable attention in gene delivery applications. First, they were shown to increase the transfection with adenovirus and lentivirus vectors. Second, they were shown to increase expression of genes delivered into cells using non-viral vectors. Third, the conjugates of Pluronic with polycations, were used as DNA-condensing agents to form polyplexes. Finally, it was demonstrated that they can increase regional expression of the naked DNA after its injection in the skeletal and cardiac muscles or tumor. Therefore, there is substantial evidence that Pluronic block copolymers can improve gene expression with different delivery routes and different types of vectors, including naked DNA. These results and possible mechanisms of Pluronic effects are discussed. At least in some cases, Pluronic can act as biological adjuvants by activating selected signaling pathways, such as NF-kappaB, and upregulating the transcription of the genes.

Entities:  

Year:  2005        PMID: 16243066     DOI: 10.1016/S0065-2660(05)53009-8

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  10 in total

1.  Combined pluronic P85- and ultrasound contrast agents-mediated gene transfection to HepG2 cells.

Authors:  Xijun Zhang; Kaiyan Li; Xian Cui; Liangjun Hu; Yunchao Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

2.  Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers.

Authors:  Vivek Mahajan; Zagit Gaymalov; Daria Alakhova; Richa Gupta; Irving H Zucker; Alexander V Kabanov
Journal:  Biomaterials       Date:  2015-10-09       Impact factor: 12.479

3.  Cytotoxicity of iron oxide nanoparticles made from the thermal decomposition of organometallics and aqueous phase transfer with Pluronic F127.

Authors:  Marcela Gonzales; Lee M Mitsumori; John V Kushleika; Michael E Rosenfeld; Kannan M Krishnan
Journal:  Contrast Media Mol Imaging       Date:  2010 Sep-Oct       Impact factor: 3.161

4.  Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library.

Authors:  Mini Thomas; James J Lu; Chengcheng Zhang; Jianzhu Chen; Alexander M Klibanov
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

5.  Novel graft copolymers enhance in vitro delivery of antisense oligonucleotides in the presence of serum.

Authors:  Lavanya Y Peddada; Nicole K Harris; David I Devore; Charles M Roth
Journal:  J Control Release       Date:  2009-08-20       Impact factor: 9.776

Review 6.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.

Authors:  Elena V Batrakova; Alexander V Kabanov
Journal:  J Control Release       Date:  2008-04-24       Impact factor: 9.776

7.  Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model.

Authors:  C-S Chen; Y Jounaidi; T Su; D J Waxman
Journal:  Cancer Gene Ther       Date:  2007-09-14       Impact factor: 5.987

8.  The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells.

Authors:  Zagit Z Gaymalov; Zhihui Yang; Vladimir M Pisarev; Valery Yu Alakhov; Alexander V Kabanov
Journal:  Biomaterials       Date:  2008-12-07       Impact factor: 12.479

9.  DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination.

Authors:  Dorian McIlroy; Benoît Barteau; Jeannette Cany; Peggy Richard; Clothilde Gourden; Sophie Conchon; Bruno Pitard
Journal:  Mol Ther       Date:  2009-05-05       Impact factor: 11.454

10.  SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals.

Authors:  Sophie Bouyon; Véronique Roussel; Yves Fromes
Journal:  Hum Gene Ther       Date:  2014-08       Impact factor: 5.695

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.